BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22045168)

  • 1. Brief cognitive assessment in the early stages of Parkinson disease.
    Bugalho P; Vale J
    Cogn Behav Neurol; 2011 Dec; 24(4):169-73. PubMed ID: 22045168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontal assessment battery in patients with Parkinson disease in a Turkish population.
    Kenangil G; Orken DN; Ur E; Forta H
    Cogn Behav Neurol; 2010 Mar; 23(1):26-8. PubMed ID: 20299860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressive symptoms in Parkinson disease correlate with impaired global and specific cognitive performance.
    Fernandez HH; See RH; Gary MF; Bowers D; Rodriguez RL; Jacobson C; Okun MS
    J Geriatr Psychiatry Neurol; 2009 Dec; 22(4):223-7. PubMed ID: 19429848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The frontal assessment battery as a tool for evaluation of frontal lobe dysfunction in patients with Parkinson disease.
    Cohen OS; Vakil E; Tanne D; Molshatzki N; Nitsan Z; Hassin-Baer S
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):71-7. PubMed ID: 22689698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression impairs executive functioning in Parkinson disease patients with low educational level.
    Kummer A; Harsányi E; Dias FM; Cardoso F; Caramelli P; Teixeira AL
    Cogn Behav Neurol; 2009 Sep; 22(3):167-72. PubMed ID: 19741326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomic and cognitive functions in Parkinson's disease (PD).
    Oh ES; Lee JH; Seo JG; Sohn EH; Lee AY
    Arch Gerontol Geriatr; 2011; 52(1):84-8. PubMed ID: 20223528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive status correlates with neuropathologic stage in Parkinson disease.
    Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
    Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.
    Kulisevsky J; Pagonabarraga J
    Mov Disord; 2009 Jun; 24(8):1103-10. PubMed ID: 19353727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based case-control study of cognitive function in early Parkinson's disease (NEDICES).
    Benito-León J; Louis ED; Posada IJ; Sánchez-Ferro Á; Trincado R; Villarejo A; Mitchell AJ; Bermejo-Pareja F
    J Neurol Sci; 2011 Nov; 310(1-2):176-82. PubMed ID: 21774946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing cognition in Parkinson disease: use of the cognitive linguistic quick test.
    Parashos SA; Johnson ML; Erickson-Davis C; Wielinski CL
    J Geriatr Psychiatry Neurol; 2009 Dec; 22(4):228-34. PubMed ID: 19666882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive profile of patients with newly diagnosed Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Neurology; 2005 Oct; 65(8):1239-45. PubMed ID: 16247051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The frontal assessment battery at bed side(FAB) in patients with Parkinson's disease].
    Takagi R; Kajimoto Y; Kamiyoshi S; Miwa H; Kondo T
    No To Shinkei; 2002 Oct; 54(10):897-902. PubMed ID: 12476579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premotor cognitive status in a cohort of incident Parkinson disease patients (NEDICES).
    Sánchez-Ferro Á; Benito-León J; Mitchell AJ; Louis ED; Posada IJ; Trincado R; Villarejo A; Bermejo-Pareja F
    J Neurol Sci; 2011 Nov; 310(1-2):211-5. PubMed ID: 21621225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual dysfunction in Parkinson disease without dementia.
    Uc EY; Rizzo M; Anderson SW; Qian S; Rodnitzky RL; Dawson JD
    Neurology; 2005 Dec; 65(12):1907-13. PubMed ID: 16282276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MoCA: well-suited screen for cognitive impairment in Parkinson disease.
    Dalrymple-Alford JC; MacAskill MR; Nakas CT; Livingston L; Graham C; Crucian GP; Melzer TR; Kirwan J; Keenan R; Wells S; Porter RJ; Watts R; Anderson TJ
    Neurology; 2010 Nov; 75(19):1717-25. PubMed ID: 21060094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of fitness to drive in people with Parkinson disease.
    Devos H; Vandenberghe W; Nieuwboer A; Tant M; Baten G; De Weerdt W
    Neurology; 2007 Oct; 69(14):1434-41. PubMed ID: 17909156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenging the serotonergic system in Parkinson disease patients: effects on cognition, mood, and motor performance.
    Scholtissen B; Verhey FR; Adam JJ; Weber W; Leentjens AF
    Clin Neuropharmacol; 2006; 29(5):276-85. PubMed ID: 16960473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.